(via www.magicdiligence.com)
Questcor derives substantially all of its revenues from H.P. Acthar, an anti-inflammatory agent used for treatment of multiple sclerosis and infantile spasms. The company's future depends on how long they can maintain the very high selling price for Acthar against several competitive threats.
Recent comments
1 hour 51 min ago
1 day 12 hours ago
3 days 10 hours ago
3 days 14 hours ago
1 week 4 hours ago
4 weeks 4 hours ago
5 weeks 23 hours ago
7 weeks 3 days ago
8 weeks 1 day ago
8 weeks 1 day ago